Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03082534 |
| Title | Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Assuntina G. Sacco |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCSD Moores Cancer Center | La Jolla | California | 92093 | United States | Details | |
| University of California Los Angeles Cancer Center | Los Angeles | California | 90095 | United States | Details | |
| University of Michigan Cancer Center | Ann Arbor | Michigan | 48109 | United States | Details | |
| Washington School of Medicine Cancer Center | Saint Louis | Missouri | 63110 | United States | Details |